Jefferies LLC

The Bombay Stock Exchange has announced a marketing range for its long-awaited IPO in India, leaving no doubt that the Rp12.4bn ($182m) deal will price at the top of expectations.

The sterling high yield bond market on Friday priced its first single-B rated issue of the year, a £275m note from Amigo Loans, a UK consumer lender, with the third highest coupon in the past 12 months for a single-B sterling issue.

India’s second largest stock exchange BSE is set to launch bookbuilding for its potential $200m listing in the last week of January, according to a red herring prospectus filed by the bourse.

UK guarantor loans company Amigo Loans on Wednesday became the third European business to launch a high yield bond this year and the second to list on the increasingly popular Channel Islands Securities Exchange.

Syndication of Elysium Healthcare’s reduced £133m loan has run over into 2017 at investors’ requests, according to a banker on the deal, as the European leveraged loan market returns with expectations of a healthy New Year pipeline.

India’s two main stock exchanges are set to start 2017 on a positive note, with Bombay Stock Exchange (BSE) likely to launch a $200m deal this month and National Stock Exchange (NSE) bringing a jumbo $1bn IPO in the second quarter.

Shares in Greencore, the Anglo-Irish sandwich and convenience food producer, closed 3% higher on Wednesday after it completed its £439m rights issue to finance its acquisition of Peacock Foods, a US competitor.

Gitanjali Gems is seeking to list its wholly-owned subsidiary Nakshatra World in an IPO that will raise up to Rp6.5bn ($95.9m).

Another piece of next year’s equity capital markets issuance puzzle was turned over today, when Lonza, the Swiss pharmaceutical and chemical company, announced a Sfr3.3bn rights issue to pay for the acquisition of Capsugel from KKR.

Laurus Labs, the Indian pharmaceutical firm, is on track to raise Rp13.3bn ($197.0m) after it wrapped up bookbuilding on Thursday and was more than 4x covered.

Banca Monte dei Paschi’s shares leapt 7% on Wednesday morning, on growing hopes that a way will be found for the Italian state to strengthen its balance sheet, enabling it to achieve a €5bn capital raising demanded by the European Central Bank and avoid a bail-in.

Tonight, Nordic Nanovector, the Norwegian developer of radio-immunotherapeutics for haematological cancers, is raising Nkr527m ($63m) to finance clinical trials, by placing new shares with institutional investors.